| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 7e-05 |